FINWIRES · TerminalLIVE
FINWIRES

Evolus Plans to Launch Estyme Collection in Europe

By

Evolus (EOLS) said Monday that it will launch Estyme, its injectable hyaluronic acid gel collection, in Europe on May 16.

The company said that the Estyme collection includes four injectable hyaluronic acid gels, including its Estyme Sculpt product, which has been developed to restore mid-face volume.

Evolus said that the commercial launch in the region follows its successful CE Mark certification under the European Medical Device Regulation.

Shares of the company were up 3% in early Monday trading.

Price: $6.55, Change: $+0.19, Percent Change: +2.91%

Related Articles

Australia

SoFi Technologies Taking Over Fintech PrimaryBid, Sky News Reports

Price: $15.96, Change: $+0.21, Percent Change: +1.30%

$SOFI
Australia

Celanese's H2 Guide Appears Conservative, RBC Says

Celanese's (CE) H2 guidance looks conservative but its engineered materials business faces some headwinds from inventory drawdowns, RBC Capital Markets said in a Friday note.The report said the company's H2 EPS guide of about $3.00 is likely below buy-side expectations while its guidance for Q2 of about $2.20 is encouraging."Overall, CE continues to see subdued end-use demand,with pockets of strength in vinyl emulsions, redispersible powders, medical, electronics, data-centers, and some industrial applications," the note said.The report also said improving free cash flow generation is facilitating its deleveraging plan.RBC reiterated its sector perform rating and raised its price target to $68 per share from $66.Price: $59.43, Change: $+2.26, Percent Change: +3.95%

$CE
Australia

Correction: --Earnings Flash (TKC) Turkcell Iletisim Hizmetleri Posts Q1 Total Revenue 68.38B Turkish Lira, vs. 62.77 billion a year earlier.

Price: $6.69, Change: $+0.04, Percent Change: +0.68%

$TKC